Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.bayer.com/media/en-us/first-patient-randomized-in-askbio-phase-ii-gene-therapy-trial-for-congestive-heart-failure/
https://www.bayer.com/media/en-us/bayers-askbio-initiates-phase-ii-genephit-trial-in-congestive-heart-failure-chf/
https://endpts.com/bayer-and-askbio-reveal-early-safety-data-for-parkinsons-gene-therapy-plot-phii-study/
https://www.indianpharmapost.com/news/askbio-announces-first-patient-randomized-in-phase-1-trial-of-ab-1005-14911
https://www.bayer.com/media/en-us/askbio-presents-preliminary-data-from-phase-1-trial-of-gene-therapy-for-congestive-heart-failure-chf-at-the-2023-american-heart-association-scientific-sessions/
https://www.prnewswire.com/news-releases/askbio-contribution-to-advancing-gene-therapy-highlighted-at-esgct-30th-congress-301964479.html
https://www.prnewswire.com/news-releases/askbio-announces-first-patient-dosed-in-phase-1--phase-2-trial-of-ab-1003-gene-therapy-for-limb-girdle-muscular-dystrophy-type-2ir9-lgmd2ir9-301892324.html
https://www.prnewswire.com/news-releases/taav-launches-new-corporate-brand-as-a-reflection-of-its-transformation-301812622.html
https://www.prnewswire.com/news-releases/askbio-to-present-phase-1b-results-investigating-ab-1005-formerly-aav2-gdnf-as-treatment-for-parkinsons-disease-at-adpdtm-2023-international-conference-on-alzheimers-and-parkinsons-diseases-301785198.html